Sample Request

Global Fabrazyme-Drug Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

SELECT LICENSE:

Published on 08/10/2021| Code: MAR41115D| Category: Healthcare & Life Sciences| Total Pages: 118

Fabrazyme (agalsidase beta) is a man-made form of the naturally-occurring alpha-galactosidase A enzyme. A deficiency of this enzyme is called Fabry disease. Agalsidase beta reduces deposits of globotriaosylceramide (GL-3) in the kidneys and certain other cells in the body. Fabrazyme is used in the treatment of Fabry disease.

Based on the Fabrazyme-Drug market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Fabrazyme-Drug market covered in Chapter 5:

Amicus Therapeutics
GlaxoSmithKline
Protalix Biotherapeutics
Novartis Pharmaceuticals
Shire
Amgen Inc.
Sanofi-Genzyme

In Chapter 6, on the basis of types, the Fabrazyme-Drug market from 2015 to 2025 is primarily split into:

White Lyophilized Cake
White Lyophilized Powder

In Chapter 7, on the basis of applications, the Fabrazyme-Drug market from 2015 to 2025 covers:

Fabry Disease
Other Disease

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Fabrazyme-Drug Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 Amicus Therapeutics
5.1.1 Amicus Therapeutics Company Profile
5.1.2 Amicus Therapeutics Business Overview
5.1.3 Amicus Therapeutics Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Amicus Therapeutics Fabrazyme-Drug Products Introduction
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Company Profile
5.2.2 GlaxoSmithKline Business Overview
5.2.3 GlaxoSmithKline Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 GlaxoSmithKline Fabrazyme-Drug Products Introduction
5.3 Protalix Biotherapeutics
5.3.1 Protalix Biotherapeutics Company Profile
5.3.2 Protalix Biotherapeutics Business Overview
5.3.3 Protalix Biotherapeutics Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Protalix Biotherapeutics Fabrazyme-Drug Products Introduction
5.4 Novartis Pharmaceuticals
5.4.1 Novartis Pharmaceuticals Company Profile
5.4.2 Novartis Pharmaceuticals Business Overview
5.4.3 Novartis Pharmaceuticals Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Novartis Pharmaceuticals Fabrazyme-Drug Products Introduction
5.5 Shire
5.5.1 Shire Company Profile
5.5.2 Shire Business Overview
5.5.3 Shire Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Shire Fabrazyme-Drug Products Introduction
5.6 Amgen Inc.
5.6.1 Amgen Inc. Company Profile
5.6.2 Amgen Inc. Business Overview
5.6.3 Amgen Inc. Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Amgen Inc. Fabrazyme-Drug Products Introduction
5.7 Sanofi-Genzyme
5.7.1 Sanofi-Genzyme Company Profile
5.7.2 Sanofi-Genzyme Business Overview
5.7.3 Sanofi-Genzyme Fabrazyme-Drug Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Sanofi-Genzyme Fabrazyme-Drug Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global Fabrazyme-Drug Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global Fabrazyme-Drug Sales and Market Share by Types (2015-2020)

6.1.2 Global Fabrazyme-Drug Revenue and Market Share by Types (2015-2020)

6.1.3 Global Fabrazyme-Drug Price by Types (2015-2020)

6.2 Global Fabrazyme-Drug Market Forecast by Types (2020-2025)

6.2.1 Global Fabrazyme-Drug Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global Fabrazyme-Drug Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global Fabrazyme-Drug Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global Fabrazyme-Drug Sales, Price and Growth Rate of White Lyophilized Cake
6.3.2 Global Fabrazyme-Drug Sales, Price and Growth Rate of White Lyophilized Powder
6.4 Global Fabrazyme-Drug Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 White Lyophilized Cake Market Revenue and Sales Forecast (2020-2025)
6.4.2 White Lyophilized Powder Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global Fabrazyme-Drug Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global Fabrazyme-Drug Sales and Market Share by Applications (2015-2020)

7.1.2 Global Fabrazyme-Drug Revenue and Market Share by Applications (2015-2020)

7.2 Global Fabrazyme-Drug Market Forecast by Applications (2020-2025)

7.2.1 Global Fabrazyme-Drug Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global Fabrazyme-Drug Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global Fabrazyme-Drug Revenue, Sales and Growth Rate of Fabry Disease (2015-2020)
7.3.2 Global Fabrazyme-Drug Revenue, Sales and Growth Rate of Other Disease (2015-2020)
7.4 Global Fabrazyme-Drug Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Fabry Disease Market Revenue and Sales Forecast (2020-2025)
7.4.2 Other Disease Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global Fabrazyme-Drug Sales by Regions (2015-2020)

8.2 Global Fabrazyme-Drug Market Revenue by Regions (2015-2020)

8.3 Global Fabrazyme-Drug Market Forecast by Regions (2020-2025)

9 North America Fabrazyme-Drug Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America Fabrazyme-Drug Market Sales and Growth Rate (2015-2020)

9.3 North America Fabrazyme-Drug Market Revenue and Growth Rate (2015-2020)

9.4 North America Fabrazyme-Drug Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America Fabrazyme-Drug Market Analysis by Country

9.6.1 U.S. Fabrazyme-Drug Sales and Growth Rate

9.6.2 Canada Fabrazyme-Drug Sales and Growth Rate

9.6.3 Mexico Fabrazyme-Drug Sales and Growth Rate

10 Europe Fabrazyme-Drug Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe Fabrazyme-Drug Market Sales and Growth Rate (2015-2020)

10.3 Europe Fabrazyme-Drug Market Revenue and Growth Rate (2015-2020)

10.4 Europe Fabrazyme-Drug Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe Fabrazyme-Drug Market Analysis by Country

10.6.1 Germany Fabrazyme-Drug Sales and Growth Rate

10.6.2 United Kingdom Fabrazyme-Drug Sales and Growth Rate

10.6.3 France Fabrazyme-Drug Sales and Growth Rate

10.6.4 Italy Fabrazyme-Drug Sales and Growth Rate

10.6.5 Spain Fabrazyme-Drug Sales and Growth Rate

10.6.6 Russia Fabrazyme-Drug Sales and Growth Rate

11 Asia-Pacific Fabrazyme-Drug Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific Fabrazyme-Drug Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific Fabrazyme-Drug Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific Fabrazyme-Drug Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific Fabrazyme-Drug Market Analysis by Country

11.6.1 China Fabrazyme-Drug Sales and Growth Rate

11.6.2 Japan Fabrazyme-Drug Sales and Growth Rate

11.6.3 South Korea Fabrazyme-Drug Sales and Growth Rate

11.6.4 Australia Fabrazyme-Drug Sales and Growth Rate

11.6.5 India Fabrazyme-Drug Sales and Growth Rate

12 South America Fabrazyme-Drug Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America Fabrazyme-Drug Market Sales and Growth Rate (2015-2020)

12.3 South America Fabrazyme-Drug Market Revenue and Growth Rate (2015-2020)

12.4 South America Fabrazyme-Drug Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America Fabrazyme-Drug Market Analysis by Country

12.6.1 Brazil Fabrazyme-Drug Sales and Growth Rate

12.6.2 Argentina Fabrazyme-Drug Sales and Growth Rate

12.6.3 Columbia Fabrazyme-Drug Sales and Growth Rate

13 Middle East and Africa Fabrazyme-Drug Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa Fabrazyme-Drug Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa Fabrazyme-Drug Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa Fabrazyme-Drug Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa Fabrazyme-Drug Market Analysis by Country

13.6.1 UAE Fabrazyme-Drug Sales and Growth Rate

13.6.2 Egypt Fabrazyme-Drug Sales and Growth Rate

13.6.3 South Africa Fabrazyme-Drug Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005